The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of activation levels of TIE2 with response to the angiogenesis inhibitor trebananib in HER2+ patients in the I-SPY 2 trial.
 
Rosa Isela Gallagher
No Relationships to Disclose
 
Julia Dianne Wulfkuhle
Honoraria - Dava Oncology
Patents, Royalties, Other Intellectual Property - Patents Royalties
 
Christina Yau
Employment - NantWorks
 
Denise M Wolf
No Relationships to Disclose
 
Lamorna Brown Swigart
No Relationships to Disclose
 
Gillian L. Hirst
No Relationships to Disclose
 
Laura Esserman
No Relationships to Disclose
 
Donald A. Berry
Employment - Berry Consultants
Leadership - Berry Consultants
Stock and Other Ownership Interests - Berry Consultants
Consulting or Advisory Role - Berry Consultants
Travel, Accommodations, Expenses - Berry Consultants
 
Laura van 't Veer
No Relationships to Disclose
 
Emanuel Petricoin
Leadership - Ceres Nanosciences; Perthera
Stock and Other Ownership Interests - Avant Diagnostics; Ceres Nanosciences; Perthera
Consulting or Advisory Role - Avant Diagnostics; AZGen; Ceres Nanosciences; Perthera
Research Funding - Abbvie (Inst); Ceres Nanosciences (Inst); GlaxoSmithKline (Inst); Symphony Evolution (Inst)
Patents, Royalties, Other Intellectual Property - NIH Patents Licensing Fee Distribution/Royalty; University assigned patent licensing fee/royalty
Travel, Accommodations, Expenses - Ceres Nanosciences; Perthera